Barrington analyst Michael Petusky downgraded Surmodics (SRDX) to Underperform from Market Perform given that shares are now trading within 3.3% of the GTCR merger offer. The firm thinks investors should consider exiting the position and sees little to no possibility of a higher bid emerging at this point, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX:
- SurModics Merger with GTCR LLC Clears Legal Hurdle
- Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
- Morning Movers: Nvidia dips after SoftBank sells out of stake
- Surmodics confirms District Court denies request for preliminary injunction
- Surmodics acquisition by GTCR can proceed, Reuters reports